Sport-Conflicting ideas of fairness in women’s sports fuel transgender participation debate

The latest flashpoint emerged from comments made by Indiana Fever guard Sophie Cunningham, who, in an ESPN interview last month, articulated a viewpoint shared by many athletes and parents: that young girls in sport “shouldn’t have to go against biological men.” Her statement, while praised by some as a courageous stance, drew sharp criticism from others who viewed it as transphobic and exclusionary. Cunningham’s remarks underscored the raw emotions and deeply held convictions surrounding the topic, illustrating how even a single comment from a prominent athlete can amplify a global discussion. The immediate wave of support and backlash she experienced highlighted the polarized nature of the debate, where calls for "fairness" are interpreted through vastly different lenses.

This public discourse follows significant policy shifts by major sports organizations. Both the Women’s Tennis Association (WTA) and the International Olympic Committee (IOC) have recently updated their eligibility policies, introducing a requirement for athletes to clear one-time SRY gene tests. The SRY gene, located on the Y chromosome, plays a crucial role in initiating male sex development. By mandating this test, these bodies aim to provide a clearer, biological determinant of sex for competition in the women’s category at the Olympics and on the women’s professional tennis tour. This marks a departure from previous policies, which often focused on testosterone levels, and signifies a move towards a more explicit biological criterion for eligibility. Other international federations, such as World Athletics and World Aquatics (formerly FINA), have adopted similar or even stricter guidelines, effectively excluding transgender women who have undergone male puberty from competing in the female category.

At the heart of the debate are fundamentally conflicting views on what constitutes "fairness" in sports. One perspective, championed by groups like the Independent Council on Women’s Sport (ICONS), argues that competitive fairness and the integrity of women’s sports categories can only be maintained by restricting participation to biological women. Kim Jones, co-founder of ICONS, articulated this view, stating, “When you recognise that a category needs to exist in order to include an entire population in sport, you have to define that boundary clearly and protect it.” This argument is rooted in the widely accepted scientific understanding that individuals assigned male at birth, having undergone male puberty, typically possess inherent physiological advantages in strength, speed, and endurance compared to biological females, regardless of subsequent hormone therapy. These advantages, including greater bone density, muscle mass, lung capacity, and heart size, are seen as fundamentally altering the competitive balance in sports designed for biological females.

Conversely, advocacy groups like the Sport & Rights Alliance contend that barring transgender women from women’s sports is inherently exclusionary and prevents access to the profound benefits of athletic participation. Andrea Florence, executive director of the Sport & Rights Alliance, expressed concern that the debate itself distracts from other pressing challenges in women’s sports, such as harassment, unequal pay, and inadequate funding. Florence also criticized the implementation of sex-testing policies, deeming them harmful and discriminatory. “We should be talking about removing barriers (for) women and girls to access sports and not adding to them,” she asserted, highlighting the potential for these policies to create further obstacles for marginalized athletes. She further noted that while the debate has limited statistical relevance in terms of the number of transgender athletes involved, it holds "big relevance when it comes to narrative," suggesting it fuels a moral panic that overshadows real issues.

INSIDE THE DEBATE: Nuances and Data

The contention is further complicated by the scarcity of openly transgender athletes competing at elite levels. American grand-slam winner Coco Gauff weighed in on the discussion this month, affirming her support for fairness in sports but expressing discomfort with the animosity being directed towards the transgender community. Her nuanced stance reflects a desire to uphold competitive integrity while fostering an environment of respect.

Lily Dong Li Rosengard, an advocacy senior specialist at ILGA World, a federation of LGBTQ+ rights groups, echoed Gauff’s sentiment regarding the narrative surrounding transgender athletes. “There is this narrative that transgender women and girls dominate women’s sports but in reality (they) are wildly under-represented in athletics globally,” Rosengard stated. This observation is supported by the current landscape: there are no active openly transgender players on the WTA or in the WNBA. The 2020 Tokyo Olympics marked a significant, albeit rare, milestone as New Zealand weightlifter Laurel Hubbard became the first openly transgender woman to compete at the Games, generating considerable media attention and controversy. Her participation, however, did not lead to a medal, and she has since retired, further underscoring the limited presence of transgender women at the pinnacle of sports. This data suggests that the "threat" of transgender dominance in women’s sports, often invoked in public discourse, may be largely disproportionate to the actual numbers.

Emma Hilton, interim chair of the charity Sex Matters, while acknowledging the low numbers, emphasized the fundamental principle of category protection. “I don’t think women’s sports is about to collapse under the weight of carrying transgender women,” Hilton conceded, but maintained that her conception of fairness is rooted in the argument that all sports categories require clear, enforced boundaries, whether based on age, weight, or sex. “If you have male pattern development, you shouldn’t be in women’s sport because that category is exclusive – it discriminates against people with male patterns of development,” Hilton argued. “That’s the only way it can exist as the category.” This perspective views sex as a primary biological differentiator that fundamentally impacts athletic performance, requiring segregation to ensure fair competition for biological females.

The International Olympic Committee’s stance, reiterated in March, aligns with this biological advantage argument. Its working group concluded that “male sex provides a performance advantage in all sports and events that rely on strength, power and endurance.” Consequently, the IOC asserted that its new policy “protects fairness, safety and integrity in the female category,” prioritizing biological sex as the key determinant for eligibility in certain women’s events. This position reflects a growing consensus among some scientific and sporting bodies that the advantages conferred by male puberty are largely irreversible and significant enough to warrant exclusion from female categories, even with testosterone suppression.

ELIGIBILITY CRITERIA: Implementation and Impact

As more sports governing bodies adopt sex testing, significant concerns have been raised about the potential impact on transgender women and their fundamental access to sport. The practical implementation of these policies often requires defining what constitutes a "woman" in a sporting context, a task Hilton acknowledged as "really uncomfortable for some people," given the complex interplay of biological, social, and legal definitions of sex and gender.

The evolution of eligibility policies highlights this complexity. The previous WTA policy, for instance, permitted transgender women to participate if they declared their gender as female and then maintained a lowered testosterone level for a period of two years prior to competing. This approach, similar to the IOC’s 2015 guidelines, focused on mitigating perceived advantages through hormone regulation. However, the move to SRY gene testing signals a shift towards a more immutable biological characteristic. The IOC’s updated policy states that athletes with an SRY-positive screen are eligible to compete in all other classifications for which they qualify, including any male category.

This provision, however, is met with skepticism by advocates for transgender inclusion. Rosengard, for example, believes that such policies effectively end the athletic careers of many transgender women. “Trans women are not just going to compete in the men’s category. They’re just not going to compete at all,” she predicted. The reasons are multifaceted: many transgender women would face insurmountable competitive disadvantages against cisgender men, and competing in a male category could be profoundly dysphoric, invalidating their gender identity and potentially exposing them to social stigma or even danger. Rosengard views the IOC’s broader 2021 framework on fairness and inclusion, which states that eligibility criteria should be established and implemented fairly in a way that does not “systematically exclude athletes from competition based upon their gender identity, physical appearance and/or sex variations,” as a positive step, contrasting it with the perceived exclusionary nature of the SRY gene test for specific events.

Andrea Florence of the Sport & Rights Alliance pointed out another critical consequence: the new IOC policy, like previous testosterone-based regulations, also affects athletes with Differences in Sex Development (DSD). These individuals, who might be raised as female but possess XY sex chromosomes and blood testosterone levels in the male range, have historically faced invasive and discriminatory eligibility requirements. “It puts a lot of barriers. But the main issue is also that it does nothing to ensure that their participation at the grassroots level is not impacted,” Florence warned, expressing concern that such policies could deter participation at all levels, from recreational to professional. Her organization recently urged the WTA to abandon sex testing altogether, citing human rights concerns.

Player reactions to these policy changes have also been varied. Earlier this month, world number one Aryna Sabalenka publicly backed the WTA’s policy, indicating a pragmatic acceptance within the professional tennis community. Similarly, American Jessica Pegula stated she had not heard any negative feedback from fellow players about the one-time testing, which is conducted via a relatively non-invasive cheek swab or blood test. This suggests that for many athletes, clarity and a definitive policy, even if controversial to some, might be preferred over ambiguity.

However, the historical struggles of DSD athletes underscore the deeply personal and often traumatic impact of sex testing. Double Olympic champion Caster Semenya, a DSD athlete whose career has been significantly hampered by regulations requiring her to lower her natural testosterone levels, has vowed to fight against the IOC’s introduction of gene testing. Semenya has consistently argued that such policies undermine women’s rights and dignity, forcing athletes to undergo unnecessary medical interventions or face exclusion from the sport they love. Her ongoing legal battles serve as a powerful reminder of the human cost associated with these complex eligibility criteria.

Regarding the methodology of sex verification, Emma Hilton does not support the practice of genital inspection, a historically traumatic and dehumanizing method. For her, modern-day sex testing, such as SRY gene screening, represents the “least harmful way” to enforce eligibility in women’s sports, provided further screening is done privately and without publicly identifying athletes. “That’s the rationale for sex screening, I think; it is the least invasive, most dignified, most private way to do this,” Hilton concluded. This perspective suggests that while sex testing itself is a sensitive issue, there are methods that can minimize harm while still upholding the principle of biological segregation for competitive fairness.

In conclusion, the debate over transgender participation in women’s sports is a multi-faceted challenge, deeply rooted in conflicting interpretations of fairness, inclusion, and biological reality. While a small number of transgender athletes compete at elite levels, the narrative surrounding their participation has a disproportionately large impact, driving policy changes and fueling intense public discussion. The shift towards SRY gene testing by major sporting bodies represents a move towards more explicit biological criteria, aiming to protect the women’s category. However, this approach raises profound human rights concerns, particularly for transgender and DSD athletes, who risk exclusion and psychological harm. As sports continue to grapple with these complex issues, finding a universally accepted solution that balances competitive integrity with the fundamental right to participate remains an elusive goal, highlighting the ongoing tension between different visions for the future of women’s sports.